Anna Mangiagalli

Plasma Homocysteine and l-DOPA Metabolism in Patients with Parkinson Disease

Fabio Blandini, Roberto Fancellu, E. Martignoni et al. · Clinical Chemistry · 2001 · 106 citations · Full text

Lipid Peroxidation, Neurochemical Biomarkers, Redox Biology +20

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson?s disease. The effect of dopaminergic treatment

Fabio Blandini, Marco Cosentino, Anna Mangiagalli et al. · Journal of Neural Transmission · 2004 · 67 citations

Mitophagy, Medicine, Apoptosis-related Protein Levels +11

Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease

Alberta Samuele, Anna Mangiagalli, Marie‐Thérèse Armentero et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2005 · 52 citations

Reductive Stress, Biochemistry, Mitochondrial Function +12

Peripheral Markers of Apoptosis in Parkinson's Disease

Fabio Blandini, Anna Mangiagalli, Marco Cosentino et al. · Annals of the New York Academy of Sciences · 2003 · 40 citations

Peripheral Markers, Apoptosis, Immunology +17

Dopaminergic Modulation of Apoptosis in Human Peripheral Blood Mononuclear Cells

Cristina Colombo, Marco Cosentino, Franca Marino et al. · Annals of the New York Academy of Sciences · 2003 · 25 citations

Apoptosis, Immunology, Blood Cell +19